Related Experiment Video
Updated: Jan 12, 2026

06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
2.8K
Itaconate-functionalized tetrahedral framework nucleic acids break the dry eye vicious cycle through dual antioxidant
Kai Jiang1, Zhenyi Lin2, Mingrui Cheng1
1Department of Ophthalmology, Eye & ENT Hospital, State Key Laboratory of Brain Function and Disorders, Fudan University, Shanghai, 200031, China.
Journal of Nanobiotechnology
|November 4, 2025
Abstract
No abstract available in PubMed .
Keywords:
Dry eye diseaseItaconate derivativeMucin-1 targetingOcular drug deliveryReactive oxygen speciesTetrahedral DNA nanostructureMore Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
951
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
951
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K

